NPQ-C6 Inhibits the BCR-ABL1-STAT5 and Induces JNK, p38-MAPK, and AKT Signaling Pathways in Human Chronic Myelogenous Leukemia Cells. Here, STAT5B is linked to chronic myelogenous leukemia, BCR-ABL1 positive.